These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 7818813

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial.
    Trauger RJ, Daigle AE, Giermakowska W, Moss RB, Jensen F, Carlo DJ.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S74-82. PubMed ID: 7552517
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Salk's HIV immunogen: an immune-based therapy in human trials since 1988.
    Crit Path AIDS Proj; 1995; (No 30):1, 20-3. PubMed ID: 11362152
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-up.
    Levine AM, Groshen S, Allen J, Munson KM, Carlo DJ, Daigle AE, Ferre F, Jensen FC, Richieri SP, Trauger RJ, Parker JW, Salk PL, Salk J.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr 01; 11(4):351-64. PubMed ID: 8601221
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cross-clade immune responses after immunization with a whole-killed gp120-depleted human immunodeficiency virus type-1 immunogen in incomplete Freund's adjuvant (HIV-1 immunogen, REMUNE) in human immunodeficiency virus type-1 seropositive subjects.
    Moss RB, Giermakowska W, Lanza P, Turner JL, Wallace MR, Jensen FC, Theofan G, Richieri SP, Carlo DJ.
    Viral Immunol; 1997 Apr 01; 10(4):221-8. PubMed ID: 9473153
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x).
    Nyhus J, Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D.
    Vaccine; 2006 Mar 06; 24(10):1543-50. PubMed ID: 16289707
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
    Hernández A, Yager JA, Wilkie BN, Leslie KE, Mallard BA.
    Vet Immunol Immunopathol; 2005 Mar 10; 104(1-2):45-58. PubMed ID: 15661330
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G.
    Vaccine; 2008 Mar 04; 26(10):1375-86. PubMed ID: 18272264
    [Abstract] [Full Text] [Related]

  • 15. Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.
    Wang F, Bade E, Kuniyoshi C, Spears L, Jeffery G, Marty V, Groshen S, Weber J.
    Clin Cancer Res; 1999 Oct 04; 5(10):2756-65. PubMed ID: 10537339
    [Abstract] [Full Text] [Related]

  • 16. Comparative analysis of HIV-1 and HIV-2 indeterminate western blot patterns.
    Ayisi NK, Aidoo M.
    West Afr J Med; 1994 Oct 04; 13(3):164-7. PubMed ID: 7841107
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M, Sabahi F, Mahboudi F, Kazemnejad A.
    Saudi Med J; 2006 Jan 04; 27(1):31-6. PubMed ID: 16432590
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.